Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for ELUT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 43.65M
March 31, 2026 55.21M
December 31, 2025 62.35M
September 30, 2025 29.41M
June 30, 2025 33.85M
March 31, 2025 39.30M
December 31, 2024 36.13M
September 30, 2024 48.41M
June 30, 2024 41.90M
March 31, 2024 35.36M
December 31, 2023 43.43M
September 30, 2023 54.58M
Date Value
June 30, 2023 52.33M
March 31, 2023 60.63M
December 31, 2022 68.84M
September 30, 2022 61.02M
June 30, 2022 52.85M
March 31, 2022 59.93M
December 31, 2021 67.17M
September 30, 2021 59.90M
June 30, 2021 69.70M
March 31, 2021 74.21M
December 31, 2020 82.81M
September 30, 2020 46.14M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Agenus, Inc. 172.69M
Amgen, Inc. 95.64B
Anika Therapeutics, Inc. 183.47M
BioCryst Pharmaceuticals, Inc. 557.85M
Imunon, Inc. 14.99M

Total Assets (Quarterly) Related Metrics